Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-22-000178
Filing Date
2022-02-01
Accepted
2022-02-01 17:04:10
Documents
1
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 sierraonco_fm4jan282022.html 4  
1 sierraonco_fm4jan282022.xml 4 8795
  Complete submission text file 0000905718-22-000178.txt   10282
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLENO THERAPEUTICS INC. 1235 RADIO ROAD, SUITE 110 REDWOOD CITY CA 94065
Business Address
Sinclair Andrew (Reporting) CIK: 0001762451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37490 | Film No.: 22579764